Evidence map›Paper›PMID 28041896›Full record

ArticleCell stem cell2017

A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland.

Shang Cai, Tomer Kalisky, Debashis Sahoo, Piero Dalerba, Weiguo Feng, Yuan Lin, Dalong Qian, Angela Kong, Jeffrey Yu, Flora Wang and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. LMO2 Regulates Epithelial-Mesenchymal Plasticity of Mammary Epithelial Cells.Journal of mammary gland biology and neoplasia · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. CXCR4Nature communications · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Shang CaiInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Tomer KaliskyDepartment of Bioengineering, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Debashis SahooInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Pediatrics, Department of Computer Science and Engineering, University of California San Diego, San Diego, CA 92123-0984, USA.
Piero DalerbaInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Pathology & Cell Biology, Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.
Weiguo FengInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA; Cancer Institute, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Yuan LinInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA; Cancer Institute, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Dalong QianInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Angela KongInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Jeffrey YuInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Flora WangInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Elizabeth Y ChenInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Ferenc A ScheerenInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Angera H KuoInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Shaheen S SikandarInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Shigeo HisamoriInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Linda J van WeeleInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Diane HeiserInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Sopheak SimInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Jessica LamInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Stephen QuakeDepartment of Bioengineering, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Michael F ClarkeInstitute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: mfclarke@stanford.edu.
Stanford University · USCalifornia Institute for Regenerative Medicine · USColumbia University Irving Medical Center · US

Funding

therapeutic Targeting of CD47 on Human Leukemia and Other Cancer Stem CellsP01CA139490 · NCI · STANFORD UNIVERSITY · PI CLARKE, MICHAEL · 2009 to 2013
$8.7M
Self-Renewal of Normal and Leukemic Stem CellsR01CA100225 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CLARKE, MICHAEL · 2004 to 2015
$2.9M
Cellular hierachy of ER- breast cancers in different ethnic groupsU01CA154209 · NCI · STANFORD UNIVERSITY · PI CLARKE, MICHAEL · 2010 to 2014
$2.5M
Application of Boolean Networks to discover stem and progenitor cellsR00CA151673 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SAHOO, DEBASHIS · 2014 to 2016
$717k
NCI NIH HHS P01 CA139490NCI NIH HHS R00 CA151673NCI NIH HHS R01 CA100225NCI NIH HHS U01 CA154209
6 · The paper itself

Abstract

Stem cells in many tissues sustain themselves by entering a quiescent state to avoid genomic insults and to prevent exhaustion caused by excessive proliferation. In the mammary gland, the identity and characteristics of quiescent epithelial stem cells are not clear. Here, we identify a quiescent mammary epithelial cell population expressing high levels of Bcl11b and located at the interface between luminal and basal cells. Bcl11b

Indexed as

Cell CycleAnimalsAntigens, CDCell LineageCell ProliferationCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Epithelial CellsFemaleGene DeletionHomeostasisMammary Glands, AnimalMice, Inbred C57BLMice, KnockoutRegenerationRepressor ProteinsAntigens, CDBcl11b protein, mouseCdkn1a protein, mouseCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Repressor ProteinsTumor Suppressor Proteinsquiescencestem cell exhaustion

Identifiers

PMID28041896
PMCPMC5341693
OpenAlexW2565466068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.